The peroxisome proliferator-activated receptors (PPARs) are members of the nuclear receptor family of ligand-activated transcription factors that heterodimerize with retinoid X receptor (RXR) isoforms to regulate gene expression. Three subtypes of PPAR have been identified and cloned: α, δ (also known as β) and γ. Many endogenous ligands have been isolated for PPARs; these include prostacyclin, fatty acids, lysophosphatidic acid and leukotriene B4. PPARs play many important roles in the cell, including lipid homeostasis, cell proliferation, differentiation, adipogenesis and immune functions and are useful in the treatment of metabolic disease. The table below summarizes the pharmacological properties of these receptors.
PPAR Target Files
|Primary Distribution||Liver, adipose tissue, kidney, heart, skeletal muscle, large intestine||Ubiquitous||Adipose tissue, lymphoid tissue, colon, liver, heart|
|Tissue Function||Fatty acid synthesis and oxidation, gluconeogenesis, ketogenesis, lipoprotein assembly||Placental and gut development, fatty acid oxidation, adaptive thermogenesis, control of cell proliferation and differentiation, tissue repair||Adipocyte differentiation, glucose homeostasis|
|Human Disease Relevance||Atherosclerosis||Atherosclerosis||Obesity and insulin resistance, type II diabetes mellitus, hypertension, atherosclerosis, cancer|
|Key Compounds||Ki Values (nM)|
GW 0742 (2229)
GW 7647 (1677)
GW 1929 (1664)
WY 14643 (1312)
GW 9662 (1508)
Find multiple products by catalog number
Follow @Tocris on Twitter
Tocris is now actively tweeting. For regular updates on news, events and special offers, follow @Tocris on Twitter.